XML 36 R30.htm IDEA: XBRL DOCUMENT v3.24.3

Share-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2024

Share-Based Payment Arrangement [Abstract]

Summary of Restricted Stock Activity

Restricted stock activity for the year ended December 31, 2023 and the nine months ended September 30, 2024 was as follows:

		RSA		Weighted Average Grant Price		PRSU		Weighted Average Grant Price		RSU		Weighted Average Grant Price		Total		Weighted Average Grant Price
Nonvested balance as of December 31, 2022		133,317		$27.95		57,435		$32.89		6,105		$25.92		196,857		$29.32
Granted (1)		—		—		34,840		35.79		54,955		34.43		89,795		34.96
Vested		(56,931)		27.03		(36,120)		31.31		(3,253)		26.06		(96,304)		28.60
Forfeited		(4,435)		30.20		—		—		(820)		36.42		(5,255)		31.17
Nonvested balance as of December 31, 2023		71,951		28.53		56,155		35.70		56,987		33.97		185,093		32.38
Granted (1)		—		—		27,614		34.76		64,747		30.13		92,361		31.52
Vested		(34,170)		26.93		(34,139)		25.43		(31,859)		20.76		(100,168)		24.46
Forfeited		(5,430)		30.35		—		—		(4,857)		36.28		(10,287)		33.15
Nonvested balance as of September 30, 2024		32,351		$29.92		49,630		$42.24		85,018		$35.87		166,999		$36.61
Unrecognized compensation cost (in thousands)		$577				$1,152				$2,433				$4,162
Weighted average remaining recognition period (in years)		1.07				1.64				2.50				2.11

(1)The number of restricted shares/units shown includes the shares that would be granted if the target level of performance is achieved related to the PRSU. The number of shares actually issued may vary. During the nine months ended September 30, 2024, an additional 10,589 were issued related to actual performance results of previously granted awards.

Share-based Payment Arrangement, Expensed and Capitalized, Amount

Share-based compensation expense related to restricted stock and ESPP included in the unaudited Consolidated Statements of Income was as follows:

		For the Three Months Ended September 30,								For the Nine Months Ended September 30,
		2024				2023				2024				2023
		(In Thousands)
Share-based compensation expense		$	649			$	643			$	1,938			$	2,349

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration